4/A

FORM 4/A SUBMISSION

Company: SANGAMO THERAPEUTICS, INC
Filed: February 26, 2020
Period of Report: February 25, 2020
Accession Number: 0001209191-20-013239

View Document ↗ View on SEC.gov ↗